Context Therapeutics Inc (CNTX)
1.39
-0.11
(-7.33%)
USD |
NASDAQ |
Nov 22, 16:00
1.32
-0.07
(-5.04%)
After-Hours: 20:00
Context Therapeutics Free Cash Flow: -31.63M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -31.63M |
| June 30, 2024 | -18.40M |
| March 31, 2024 | -19.68M |
| December 31, 2023 | -21.05M |
| September 30, 2023 | -17.75M |
| June 30, 2023 | -17.78M |
| March 31, 2023 | -15.96M |
| December 31, 2022 | -14.09M |
| Date | Value |
|---|---|
| September 30, 2022 | -15.12M |
| June 30, 2022 | -11.67M |
| March 31, 2022 | -11.19M |
| December 31, 2021 | -8.800M |
| September 30, 2021 | -4.014M |
| June 30, 2021 | -4.320M |
| March 31, 2021 | -2.562M |
| December 31, 2020 | -1.035M |
Free Cash Flow Range, Past 5 Years
-31.63M
Minimum
Sep 2024
-1.035M
Maximum
Dec 2020
-13.44M
Average
-14.60M
Median
Free Cash Flow Benchmarks
| Collegium Pharmaceutical Inc | 192.43M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.933M |
| Cash from Investing (Quarterly) | -14.76M |
| Cash from Financing (Quarterly) | -0.0446M |
| Free Cash Flow Per Share (Quarterly) | -0.2074 |
| Free Cash Flow Yield | -54.39% |